Press Releases

STEMart Launches New Force Degradation Services to Ensure Drug Stability and Safety

STEMart announced the launch of its new Force Degradation Services.

Creative BioMart Enlarged Its Offerings for Recombinant F3 Protein

Lifeasible Unveils Comprehensive Exosome Identification Services for Accurate Characterization and Quantification

Inceptua Group and Cycle Pharmaceuticals Partner for a Free Goods Programme for Patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU)

Inceptua Group and Cycle Pharmaceuticals Ltd have announced a partnership to make NITYR® Tablets available via a Free Goods Programme for eligible patients with Hereditary Tyrosinemia Type 1 and Alkaptonuria.

To Fight Superbugs, Ace Infectious Unveils Phage Therapy Development Services

CD Formulation Excels in Developing and Optimizing Micro-Reservoir Controlled-Release Drug Delivery Systems

Alfa Chemistry Introduces Bio-based Polymers, Responding to Market Demand

Digital Health Panel Developer Verisense Health Appoints New Engineering Manager in Malaysia

Chong Toh Ying has more than 16 years’ experience managing large datasets and building and leading software engineering teams that deliver fast and accurate results.

Huateng Pharma Launches Veterinary Solutions – Fluralaner and Sarolaner

Huateng Pharm offers Fluralaner (CAS NO.: 864731-61-3) and Sarolaner (CAS NO.: 1398609-39-6) from laboratory-scale development to commercial production.

PathAI Commences New Year with Strong Foundation for Growth Following Key 2023 Achievements in AI-Powered Pathology Products, Strategic Partnerships, and Leadership Team Hires

PathAI, a leading AI-powered precision pathology company, has concluded a year marked by significant growth and advancements. The company developed and launched over 20 new AI products across oncology, MASH/MASLD and IBD; launched the AISight® image management system (IMS); distributed the AISight platform and IMS to a growing footprint of more than 50 labs globally; expanded clinical trial services to encompass MASH/MASLD, IBD and oncology; and honed its leadership team to drive biopharma business, regulatory strategy, and growth initiatives. Moreover, PathAI established key partnerships, presented new data at major industry conferences, and was recognized through several industry awards. The culmination of these 2023 achievements serves to further revolutionize the field of pathology, bringing more AI-driven tools to drug development and diagnostics.

BioIVT Fuels Future Cell and Gene Therapy Breakthroughs at Advanced Therapies Week

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, will exhibit its latest Cell and Gene Therapy (CGT) innovations at Advanced Therapies Week, taking place at the Miami Beach Convention Center from January 16-19.

Biopharma PEG Unveils Expanded Azide PEG Series

Biopharma PEG, a leading provider of polyethylene glycol (PEG) derivatives, is proud to introduce an extended Azide PEG series that includes monodispersed, polydispersed, and multi-arm PEGs.

CD Formulation Newly Launches Dissolving Microneedle Preparation Services: Enhancing Drug Delivery Efficiency

Alfa Chemistry Newly Announces Offering of Click Chemistry Reagents: Azides, Terminal Alkynes, and Copper-Chelating Ligands

CD Genomics Introduces Advanced OxBS-seq Technology for Accurate Methylation Analysis

CD Genomics Unveils Groundbreaking Total RNA Sequencing and Dual RNA-seq Services

HORIBA Medical launches next generation HELO fully automated modular hematology solution

New HORIBA Evolutive Laboratory Organisation (HELO) 2.0 embeds advanced hematology technologies to offer flexible, high throughput, high quality analytical performance

Empower Your Research with Creative Proteomics' Innovative Pull-Down Assay Service

Creative Proteomics Launches Label-free Quantification Service for Advanced Protein Analysis

Creative Proteomics Launches Innovative Ubiquitinated Proteomics Service for Advanced Research